Sultana RajiaCenter for Interdisciplinary Research, Varendra University, Rajshahi, Rajshahi-6204, Bangladesh
rajia@vu.edu.bd
Kenichi KamataDepartment of Materials and Applied Chemistry, College of Science and Technology, Nihon University, Kanda-Surugadai 1-5-1, Chiyoda-Ku, Tokyo 101-0062, Japan & Graduate School of Biomedical Sciences, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-Ku, Yokohama 230-0045, Japan
kamata.kenichi@nihon-u.ac.jp
Marco GerdolDepartment of Life Sciences, University of Trieste, Via Licio Giorgieri 5, 34127 Trieste, Italy
mgerdol@units.it
Imtiaj HasanDepartment of Microbiology, Faculty of Biological Science, University of Rajshahi & Department of Biochemistry and Molecular Biology, Faculty of Science, University of Rajshahi, Rajshahi-6205, Bangladesh
imtiajbio@ru.ac.bd
Namiho MatsuzakiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan
n255268g@yokohama-cu.ac.jp
Keita YamamotoGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan
n255273e@yokohama-cu.ac.jp
Suzuna YoshimotoGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan
n245272g@yokohama-cu.ac.jp
Mayuka OhkawaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan
n235351e@yokohama-cu.ac.jp
Bishnu Pada ChatterjeeDepartment of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, WB, India
cbishnup@gmail.com
Yukiko OgawaGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7, Huis Ten Bosch, Sasebo 859-3298, Japan
yogawa@niu.ac.jp
Sarkar Mohammad Abe KawsarDepartment of Chemistry, Faculty of Science, University of Chittagong, Chittagong-4331, Bangladesh
akawsarabe@yahoo.com
Tatsuya KawasakiGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7, Huis Ten Bosch, Sasebo 859-3298, Japan
kawasakit@niu.ac.jp
Hisanori KohtsukaMisaki Marine Biological Station, School of Science, The University of Tokyo, Miura 38‑0225, Japan
kohtsuka@mmbs.s.u-tokyo.ac.jp
Masao YamadaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan & emukk LLC, Kuwana 511-0902, Japan
yamada_masao@emukk.com
Yuki FujiiGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7, Huis Ten Bosch, Sasebo 859-3298, Japan
yfujii@niu.ac.jp
Yasuhiro Ozeki (Corresponding Author)Graduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan
ozeki@yokohama-cu.ac.jp
The structure of a lectin, OXYL, derived from the feather star, Anneissia japonica (phylum Echinodermata), was analyzed from biochemistry, informatics, and 3D structural prediction. OXYL’s primary structure resembled the globular domain of complement C1q in vertebrates. Structural simulations identified OXYL as part of the C1q/TNF superfamily, characterized by a jellyroll β-sandwich fold. The subunits can form monomer to nonamer (9-mer), with trimers being the most stable. However, gel permeation chromatography indicated tetramers as the significant form. In hemagglutination inhibition tests, OXYL bound type-2 N-acetyllactosamine (LacNAc: Galβ1-4GlcNAc) and inhibited agglutination but did not bind lactose (Lac: Galβ1-4Glc). Glycan microarray analysis with 20 immobilized glycans confirmed OXYL’s specificity for type-2 LacNAc and its sialic acid α2-3 linkage. The structural simulation showed a suitable molecular docking between type-2 LacNAc and the lectin rather than lactose. OXYL bound to the LacNAc glycan on the microarray was also elucidated to capture human IgG. This finding suggests that the invertebrate C1q/TNF family lectin will mimic vertebrate C1qs, despite lacking evolutionally antibody systems, possess the potential to interact with antibodies.
The purpose of this paper is to inspire logical reasoning.